1. Home
  2. TECH vs SNEX Comparison

TECH vs SNEX Comparison

Compare TECH & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$71.08

Market Cap

9.1B

Sector

Health Care

ML Signal

HOLD

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$134.32

Market Cap

8.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECH
SNEX
Founded
1976
1924
Country
United States
United States
Employees
N/A
5400
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.9B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
TECH
SNEX
Price
$71.08
$134.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
1
Target Price
$71.82
$81.33
AVG Volume (30 Days)
4.6M
889.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
0.62%
N/A
EPS Growth
N/A
N/A
EPS
0.81
3.74
Revenue
$1,219,635,000.00
$132,378,200,000.00
Revenue This Year
$2.49
N/A
Revenue Next Year
$6.40
$4.17
P/E Ratio
$87.28
$36.73
Revenue Growth
5.23
32.53
52 Week Low
$43.20
$68.97
52 Week High
$72.16
$141.99

Technical Indicators

Market Signals
Indicator
TECH
SNEX
Relative Strength Index (RSI) 78.36 63.20
Support Level $56.38 $105.27
Resistance Level N/A N/A
Average True Range (ATR) 2.03 6.12
MACD 1.75 0.43
Stochastic Oscillator 99.43 69.10

Price Performance

Historical Comparison
TECH
SNEX

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About SNEX StoneX Group Inc.

StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

Share on Social Networks: